Advancing drug discovery for schizophrenia

Stephen R. Marder, Bryan Roth, Patrick F. Sullivan, Edward M. Scolnick, Eric J. Nestler, Mark A. Geyer, Daniel R. Welnberger, Maria Karayiorgou, Alessandro Guidotti, Jay Gingrich, Schahram Akbarian, Robert W. Buchanan, Jeffrey A. Lieberman, P. Jeffrey Conn, Stephen J. Haggarty, Amanda J. Law, Brian Campbell, John H. Krystal, Bita Moghaddam, Akira SawMarc G. Caron, Susan R. George, John A. Allen, Michelle Solis

Research output: Contribution to journalArticle

17 Scopus citations
Original languageEnglish (US)
Pages (from-to)30-43
Number of pages14
JournalAnnals of the New York Academy of Sciences
Volume1236
Issue number1
DOIs
StatePublished - Oct 2011
Externally publishedYes

    Fingerprint

Cite this

Marder, S. R., Roth, B., Sullivan, P. F., Scolnick, E. M., Nestler, E. J., Geyer, M. A., Welnberger, D. R., Karayiorgou, M., Guidotti, A., Gingrich, J., Akbarian, S., Buchanan, R. W., Lieberman, J. A., Conn, P. J., Haggarty, S. J., Law, A. J., Campbell, B., Krystal, J. H., Moghaddam, B., ... Solis, M. (2011). Advancing drug discovery for schizophrenia. Annals of the New York Academy of Sciences, 1236(1), 30-43. https://doi.org/10.1111/j.1749-6632.2011.06216.x